**Core Concept**
Salmeterol is a long-acting beta-2 adrenergic receptor agonist (LABA) used in the management of asthma and chronic obstructive pulmonary disease (COPD). Its mechanism of action involves the activation of beta-2 adrenergic receptors, leading to bronchodilation.

**Why the Correct Answer is Right**
Salmeterol binds to the beta-2 adrenergic receptor, a G-protein coupled receptor, leading to an increase in cyclic adenosine monophosphate (cAMP) levels. This increase in cAMP results in the activation of protein kinase A (PKA), which in turn leads to the relaxation of airway smooth muscles, causing bronchodilation. Salmeterol's long-acting nature allows it to maintain its effect for 12 hours, providing sustained bronchodilation.

**Why Each Wrong Option is Incorrect**
* **Option A:** Incorrect because it does not specify the beta-2 adrenergic receptor agonist mechanism of action.
* **Option B:** Incorrect because it implies a different receptor or mechanism of action, which is not relevant to salmeterol.
* **Option C:** Incorrect because it suggests a different class of drugs, such as anticholinergics, which have a different mechanism of action.

**Clinical Pearl / High-Yield Fact**
Salmeterol's long-acting nature is due to its high lipophilicity, which allows it to bind to the beta-2 adrenergic receptor for an extended period. This property makes it an effective treatment for nocturnal asthma and COPD, providing sustained bronchodilation throughout the night.

**Correct Answer:** C.